R&D
Breakdown
Segments
ZanidatamabView metric
ZW171View metric
ZW191View metric
ZW220View metric
ZW251View metric
Expense for other preclinical and research programsView metric
| Segment | Q1 '26 |
|---|---|
| Expense for other preclinical and research programs | $7.26M |
| ZW191 | $3.03M |
| ZW251 | $1.91M |
| ZW171 | $1.15M |
| Zanidatamab | $623K |
| ZW220 | $97K |
| Total | $34.46M |